A DNA aptamer with high affinity and specificity for molecular recognition and targeting therapy of gastric cancer

Background Aptamers have emerged as excellent molecular probes for cancer diagnosis and therapy. The aim of the current study was to determine the feasibility of using DNA aptamer cy-apt 20 developed by live cell-SELEX for detecting and targeting gastric cancer.